OncologyPharmacologySponsored Article

Collaboration in patient-centered care planning

Share
By: Kim Kuebler, DNP, APRN, ANP-BC, FAAN

Navigating the oncology journey

In 2023, according to the Centers for Disease Control and Prevention (CDC), cancer remained the second leading cause of death for Americans. The American Cancer Society (ACS), in 2025, identified the three leading types of adult malignancy in men as prostate, lung and bronchus, and colorectal. For women, the three most common causes of malignancy are breast, lung and bronchus, and colorectal.

The CDC, ACS, U.S. Preventive Services Taskforce, and the National Comprehensive Cancer Network all promote earlier routine screenings to prevent advanced malignancies. Earlier findings of a malignancy prevent aggressive therapies, improve prognosis, and promote improved quality of life. (See Routine screening recommendations.)

Routine screening recommendations

Breast
All women should receive screening for breast cancer every other year, starting at age 40 years and continuing through age 74
Colon
Adults age 45-75 years should receive screening for colorectal cancer. Clinicians selectively offer screening for adults age 76-85 years.
Lung
Annual lung cancer screening with low-dose computed tomography for adults, age 50-80 years with a 20-pack year smoking history. (Pack-year is calculated by multiplying the number of packs smoked per day times number of years. Example: 1 pack/day for 10 years equals 10-pack year smoker)
Prostate
Prostate specific antigen (PSA) re-screening interval can be 1-4 years for patients with PSA levels of 1-3 ng/mL between ages 45 and 70 years

Sources: U.S. Preventative Safety Task Force, National Comprehensive Cancer Network

OnDemand Webinar

Collaboration in Patient-Centered Care Planning: Navigating Oncology

Watch Now

Cancer development occurs through oncogenes—a result of abnormal cell growth generated by cancer-causing agents (carcinogens). Carcinogens directly effect normal cell structure and function by altering the cell’s DNA. Activated DNA changes occur in a normal cell through apoptosis, which generates a cancer cell. Tumor growth occurs via uncontrolled cellular proliferation and tumor progression, which allow cancer cells to invade and spread into other tissues (metastasis).

Cancer therapies are as diverse as the different types of malignancies and carry many side effects. A nurse who collaborates with the patient, family, and specialty pharmacist can help reduce side effects, prevent drug-drug interactions, support patients regarding therapy-related financial concerns, and address specific issues, such as fertility and patient self-image. (See Types of cancer therapy.)

Types of cancer therapy

Antineoplastic/chemotherapy

Groups of medications that destroy or stop the growth of chemotherapy cancer cells

  • Alkylating agents
  • Antibiotic agents
  • Antimetabolites
  • Plant Alkaloids
Biologic/targeted therapy(immunotherapy)

Uses the body’s own immune system or substances produced by living organisms

  • Cytokines
  • Gene therapy
  • Hormone therapy
  • Monoclonal Antibodies
  • Oncolytic Viruses
Radiation

High-energy radiation damages and destroys cancer cells. Frequently used in combination with surgery or chemotherapy

  • External beam radiation therapy
  • Internal radiation therapy (brachytherapy)
  • Stereotactic body radiation therapy
Surgery

Surgery plays a crucial role in cancer treatment and aids diagnosis and staging. Used to remove tumors, relieve symptoms, and prevent cancer. The type of surgery depends on the specific cancer and stage

  • Early-stage cancer: Primary treatment for localized cancers.
  • Advanced cancer: Palliative treatment used to relieve symptoms, reduce tumor size, or improve the effectiveness of other treatments.
  • Preventive: Removal of precancerous tissue or to reduce the risk of developing certain cancers.

Source: National Cancer Institute

Person-centered care planning ensures well-informed patients, adherence to therapy, and patient self-management confidence. Nurses play a key role in person-centered care by collaborating with the patient, family, and pharmacist through shared decision making, which helps to empower the patient and family so they remain in control throughout the cancer journey.

This article is sponsored and supplied to myamericannurse.com by Walgreens Co. Content has been reviewed by ANJ editorial staff but is not peer-reviewed.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.


Test Your Knowledge

In what way does emotional intelligence affect nursing leaders in team and patient care settings?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts